Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 829584, 10 pages
http://dx.doi.org/10.1155/2012/829584
Clinical Study

Emergence of Exhausted B Cells in Asymptomatic HIV-1-Infected Patients Naïve for HAART is Related to Reduced Immune Surveillance

1Section of Microbiology, Department of Experimental and Applied Medicine, University of Brescia, Spedali Civili Square, 25123 Brescia, Italy
2Institute of Infectious Tropical Diseases, School of Medicine, University of Brescia, Spedali Civili Square, 25123 Brescia, Italy
3Virology Section and Retrovirus Centre, Department of Experimental Pathology, University of Pisa, 35-37 San Zeno Road, 56127 Pisa, Italy

Received 1 September 2011; Accepted 16 November 2011

Academic Editor: Andrea Gori

Copyright © 2012 Manuela Fogli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. D. Lawn, S. T. Butera, and T. M. Folks, “Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection,” Clinical Microbiology Reviews, vol. 14, no. 4, pp. 753–777, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. H. C. Lane, H. Masur, L. C. Edgar, G. Whalen, A. H. Rook, and A. S. Fauci, “Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome,” New England Journal of Medicine, vol. 309, no. 8, pp. 453–458, 1983. View at Google Scholar · View at Scopus
  3. A. Shirai, M. Cosentino, S. F. Leitman-Klinman, and D. M. Klinman, “Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation,” Journal of Clinical Investigation, vol. 89, no. 2, pp. 561–566, 1992. View at Google Scholar · View at Scopus
  4. A. Amadori, A. De Rossi, G. P. Faulkner-Valle, and L. Chieco-Bianchi, “Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects,” Clinical Immunology and Immunopathology, vol. 46, no. 3, pp. 342–351, 1988. View at Google Scholar · View at Scopus
  5. A. M. Fournier, J. M. Fondere, C. Alix-Panabieres et al., “Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects: monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cells,” Clinical Immunology, vol. 103, no. 1, pp. 98–109, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. A. De Milito, A. Nilsson, K. Titanji et al., “Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection,” Blood, vol. 103, no. 6, pp. 2180–2186, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. De Milito, “B lymphocyte dysfunctions in HIV infection,” Current HIV Research, vol. 2, no. 1, pp. 11–21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Malaspina, S. Moir, S. Kottilil et al., “Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function,” Journal of Immunology, vol. 170, no. 12, pp. 5965–5972, 2003. View at Google Scholar · View at Scopus
  9. Y. Chong, H. Ikematsu, M. Yamamoto et al., “Increased frequency of CD27- (Naive) B cells and their phenotypic alteration in HIV type 1-infected patients,” AIDS Research and Human Retroviruses, vol. 20, no. 6, pp. 621–629, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. De Milito, C. Mörch, A. Anders Sönnerborg, and F. Chiodi, “Loss of memory (CD27) B lymphocytes in HIV-1 infection,” AIDS, vol. 15, no. 8, pp. 957–964, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Moir, A. Malaspina, O. K. Pickeral et al., “Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily,” Journal of Experimental Medicine, vol. 200, no. 5, pp. 587–599, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Moir and A. S. Fauci, “B cells in HIV infection and disease,” Nature Reviews Immunology, vol. 9, no. 4, pp. 235–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Malaspina, S. Moir, J. Ho et al., “Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2262–2267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. K. Cuss, D. T. Avery, J. L. Cannons et al., “Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity,” Journal of Immunology, vol. 176, no. 3, pp. 1506–1516, 2006. View at Google Scholar · View at Scopus
  15. S. Moir, J. Ho, A. Malaspina et al., “Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals,” Journal of Experimental Medicine, vol. 205, no. 8, pp. 1797–1805, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Bendinelli, M. Pistello, F. Maggi, C. Fornai, G. Freer, and M. L. Vatteroni, “Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans,” Clinical Microbiology Reviews, vol. 14, no. 1, pp. 98–113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Focosi, F. Maggi, M. Albani et al., “Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution,” Journal of Clinical Virology, vol. 47, no. 2, pp. 189–192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. K. Christensen, J. Eugen-Olsen, M. SŁrensen et al., “Prevalence and prognostic significance of infection with TT virus in patients infected with human immunodeficiency virus,” Journal of Infectious Diseases, vol. 181, no. 5, pp. 1796–1799, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Beq, J. F. Delfraissy, and J. Theze, “Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential,” European Cytokine Network, vol. 15, no. 4, pp. 279–289, 2004. View at Google Scholar · View at Scopus
  20. A. Llano, J. Barretina, A. Gutiérrez et al., “Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals,” Journal of Virology, vol. 75, no. 21, pp. 10319–10325, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Maggi, E. Andreoli, L. Riente et al., “Torquetenovirus in patients with arthritis,” Rheumatology, vol. 46, no. 5, pp. 885–886, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Malaspina, S. Moir, D. G. Chaitt et al., “Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7,” Blood, vol. 109, no. 5, pp. 2086–2088, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Ho, S. Moir, A. Malaspina et al., “Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 51, pp. 19436–19441, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. L. A. Napolitano, R. M. Grant, S. G. Deeks et al., “Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis,” Nature Medicine, vol. 7, no. 1, pp. 73–79, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Bolotin, G. Annett, R. Parkman, and K. Weinberg, “Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count,” Bone Marrow Transplantation, vol. 23, no. 8, pp. 783–788, 1999. View at Google Scholar · View at Scopus
  26. M. Guimond, R. G. Veenstra, D. J. Grindler et al., “Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells,” Nature Immunology, vol. 10, no. 2, pp. 149–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Hino and H. Miyata, “Torque teno virus (TTV): current status,” Reviews in Medical Virology, vol. 17, no. 1, pp. 45–57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Zhong, W. Yeo, M. W. Tang et al., “Gross elevation of TT virus genome load in the peripheral blood mononuclear cells of cancer patients,” Annals of the New York Academy of Sciences, vol. 945, pp. 84–92, 2001. View at Google Scholar · View at Scopus
  29. F. Maggi, V. Ricci, M. Bendinelli et al., “Changes in CD8+57+ T lymphocyte expansions after autologous hematopoietic stem cell transplantation correlate with changes in torquetenovirus viremia,” Transplantation, vol. 85, no. 12, pp. 1867–1868, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Moir, A. Malaspina, J. Ho et al., “Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease,” Journal of Infectious Diseases, vol. 197, no. 4, pp. 572–579, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. C. M. Mastroianni, G. Forcina, G. d'Ettorre et al., “Circulating levels of interleukin-7 in antiretroviral-naïve and highly active antiretroviral therapy-treated HIV-infected patients,” HIV Clinical Trials, vol. 2, no. 2, pp. 108–112, 2001. View at Google Scholar · View at Scopus
  32. D. R. Feikin, C. Feldman, A. Schuchat, and E. N. Janoff, “Global strategies to prevent bacterial pneumonia in adults with HIV disease,” Lancet Infectious Diseases, vol. 4, no. 7, pp. 445–455, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. E. T. Overton, S. Sungkanuparph, W. G. Powderly, W. Seyfried, R. K. Groger, and J. A. Aberg, “Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons,” Clinical Infectious Diseases, vol. 41, no. 7, pp. 1045–1048, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. F. P. Kroon, G. F. Rimmelzwaan, M. T. L. Roos et al., “Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy,” AIDS, vol. 12, no. 17, pp. F217–F223, 1998. View at Google Scholar · View at Scopus
  35. S. Pensieroso, A. Cagigi, P. Palma et al., “Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 19, pp. 7939–7944, 2009. View at Publisher · View at Google Scholar · View at Scopus